The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia

Endocrine Journal

Volumn 50, Issue 1, 2003, Pages 69-75

  Tanaka, Noriko ^a   Katsumata, Noriyuki ^a   Horikawa, Reiko ^b   Tanaka, Toshiaki ^a,b  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Achondroplasia (ACH); Growth hormone (GH) treatment; Hypochondroplasia (HCH)

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; RECOMBINANT GROWTH HORMONE;

ACHONDROPLASIA; ADOLESCENT; ARTICLE; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA DETERMINATION; DRUG EFFICACY; FEMALE; GROWTH RATE; HUMAN; HYPOCHONDROPLASIA; MALE; RECEPTOR GENE; TREATMENT OUTCOME;

ACHONDROPLASIA; BODY HEIGHT; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; LONGITUDINAL STUDIES; MALE; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; TREATMENT FAILURE;

EID: 0037296350     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.69     Document Type: Article

References (27)

1. Tachibana K, Suwa S, Nishiyama S, Matsuda I (1997) A study on the height of children with achondroplasia based on a nationwide survey. J Pediatr Prac 60: 1363-1369 (In Japanese).
2. Horton WA, Rotter JI, Rimoin DL, Calif T, Scott CI, Texas H, Hall JG, Wash S (1978) Standard growth curves for achondroplasia. J Pediatr 93: 435-438.
3. Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CGD (1990) Growth and growth hormone therapy in hypochondroplasia. Acta Pediatr Scand 79: 796-803.
4. Le Merrer M, Rousseau F, Mallet L, Landais JC, Pelet A, Bonaventure J, Sanak M, Weissenbach J, Stoll C, Munnich A, Maroteaux P (1994) A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nat Genet 6: 318-321.
5. Veilinov M, Slaugenhaupt SA, Stoilov I, Scott CI Jr, Gusella JF, Tsipouras P (1994) The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nat Genet 6: 314-317.
6. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78: 335-342.
7. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Merrer ML, Munnich A (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371: 252-254.
8. Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 10: 357-359.
9. Prinos P, Costa T, Sommer A, Kilpatrick MW, Tsipouras P (1995) A common FGFR3 gene mutation in hypochondroplasia. Hum Mol Genet 4: 2097-2101.
10. Bonaventure J, Rousseau F, Legeai-Mallet L, Le Merrer M, Munnich A, Maroteaux P (1997) Common mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for achondroplasia, hypochondroplasia and thanatophoric dwarfism. Clin Pediatr Endocrinol 6 (Suppl 10): 105-113.
11. Ramaswami U, Hindmarsh PC, Brook CGD (1999) Growth hormone therapy in hypochondroplasia. Acta Paediatr Suppl 428: 116-117.
12. Ramaswami U, Rumsby G, Spoudeas HA, Hindmarsh PC, Brook CGD (1999) Treatment of achondroplasia with growth hormone: Six years of experience. Pediatr Res 46: 435-439.
13. Seino Y, Yamanaka Y, Shinohara M, Ikegami S, Koike M, Miyazawa M, Inoue M, Moriwake T, Tanaka H (2000) Growth hormone therapy in achondroplasia. Horm Res 53 (suppl 3): 53-56.
14. Shohat M, Tick D, Barakat S, Bu X, Melmed S, Rimoin DL (1996) Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia. J Clin Endocrinol Metab 81: 4033-4037.
15. Tanaka H, Kubo T, Yamate T, Ono T, Kanzaki S, Seino Y (1998) Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype. Eur J Endocrinol 138: 275-280.
16. Key LL, Gross AJ (1996) Response to growth hormone in children with chondrodysplasia. J Pediatr 128: S14-S17.
17. Seino Y, Suwa S, Niimi H, Matsuo O, Yasui N, Shizume K, Okada Y, Tanaka T, Hibi I (1999) Efficacy and safety of growth hormone treatment in children with achondroplasia: The results of three-year growth hormone administration. Jpn J Pediatr 52: 149-161 (In Japanese).
18. Suwa S, Tachibana K, Maesaka H, Tanaka T, Yokoya S (1992) Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol 1: 5-13.
19. Sato K, Ashizawa K, Anzo M, Otsuki F, Kaneko S, Tanaka T, Tsukagoshi K, Nimura A, Matsuoka H, Matsuo N, Mitani H, Murata M (1999) Setting up an automated system for evaluation of bone age. Endocr J 46 (Suppl): S97-S100.
20. Sato K, Mitani H (1999) Evaluation of bone maturation with a computer. Clin Pediatr Endocrinol 8 (Suppl 12): 13-16.
21. Tanaka N, Satoh N, Satoh M, Tanaka T, Matsuoka N, Murata M, Anzo M, Matsuo N, Otsuki F, Satoh K, Tsukagoshi K (2001) A study on the bone mineral density of children with Turner syndrome using the standard for normal healthy children of Computer Aided Bone Density Assessment System. The 12th Japanese Society for Auxology, Tokyo, Nov. 10, 2001.
22. Fujieda K, Shimazu A, Hanew K, Tanaka T, Yokoya S, Miyaji Y, Koezuka N, Hasegawa Y, Tachibana K, Oyama K, Seino Y, Kato M, Nishi Y, Kohno H, Irie M (1996) Clinical evaluation of serum IGF-I, IGF-II, IGFBP-3 measured by IRMA kits in childhood. Clin Endocrinol 44: 91-101 (In Japanese).
23. Tanaka T, Hibi I, Takano K, Suwa S, Shizume K and the Non-Endocrine Short Stature Study Group (1996) Four-year experience of growth hormone treatment in children with non-endocrine short stature. Clin Pediatr Endocrinol 5 (Suppl 7): 1-9.
24. Ramaswami U, Rumsby G, Hindmarsh PC, Brook CGD (1998) Genotype and phenotype in hypochondroplasia. J Pediatr 133: 99-102.
25. Saggese G, Baroncelli GI, Federico G, Bertelloni S (1995) Effects of growth hormone on phosphocalcium homeostasis and bone metabolism. Horm Res 44 (Suppl 3): 55-63.
26. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8: 426-438.
27. Rao GN, Greger NG, Nelson DA (1999) Whole body bone mass and body composition in a girl with achondroplasia, at ages 9 through 12. J Clin Densitom 2: 185-190.